Top

Molecular Imaging and Biology

Published in:

01-09-2006 | Research Article

Evaluation of the Integrity of the Dopamine System in a Rodent Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Compared to Behavioral Assessment and Autoradiography

Authors: Elissa M. Strome, Ivan L. Cepeda, Vesna Sossi, Doris J. Doudet

Published in: Molecular Imaging and Biology | Issue 5/2006

Abstract

Purpose

In the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease (PD), it is important to determine lesion severity. This evaluation can be performed in vivo, through evaluation of dopamine (DA)-dependent motor function or with small animal positron emission tomography (microPET), or at postmortem, by examining markers for DA neurons.

Procedures

Rats were given mild or severe unilateral 6-OHDA lesions, scanned with the tracer [¹¹C](±)dihydrotetrabenazine ([¹¹C]DTBZ), and tested on a tapered/ledged beam-walking task. At postmortem, autoradiography was performed with [¹¹C]DTBZ.

Results

Autoradiography was significantly correlated with microPET and behavioral scores, whereas the microPET and behavioral data were not significantly correlated.

Conclusions

This study shows that behavioral analysis, microPET, and autoradiography are all good tools for measuring the integrity of the DA system, and demonstrates the utility of the tapered/ledged beam-walking test to screen for lesion severity, as well as the importance of including postmortem analysis after in vivo imaging studies.

Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107–110PubMedCrossRef

Costall B, Naylor RJ, Pycock C (1976) Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Eur J Pharmacol 35:276–283PubMed

Morelli M, Fenu S, Garau L, Di Chiara G (1989) Time and dose dependence of the ‘priming’ of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162:329–335PubMedCrossRef

Klug JM, Norman AB (1993) Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol Biochem Behav 46:397–403PubMedCrossRef

Tai YC, Ruangma A, Rowland D, et al. (2005) Performance evaluation of the microPET focus: A third-generation microPET scanner dedicated to animal imaging. J Nucl Med 46:455–463PubMed

Yang Y, Tai YC, Siegel S, et al. (2004) Optimization and performance evaluation of the microPET II scanner for in vivo small-animal imaging. Phys Med Biol 49:2527–2545PubMedCrossRef

Knoess C, Siegel S, Smith A, et al. (2003) Performance evaluation of the microPET R4 PET scanner for rodents. Eur J Nucl Med Mol Imaging 30:737–747PubMedCrossRef

Tai C, Chatziioannou A, Siegel S, et al. (2001) Performance evaluation of the microPET P4: A PET system dedicated to animal imaging. Phys Med Biol 46:1845–1862PubMedCrossRef

Tai YC, Chatziioannou AF, Yang Y, et al. (2003) MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol 48:1519–1537PubMedCrossRef

10.

Huang N, Ase AR, Hebert C, van Gelder NM, Reader TA (1997) Effects of chronic neuroleptic treatments on dopamine D₁ and D₂ receptors: Homogenate binding and autoradiographic studies. Neurochem Int 30:277–290PubMedCrossRef

11.

Rinne JO, Laihinen A, Ruottinen H, et al. (1995) Increased density of dopamine D₂ receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: A PET study with [¹¹C]raclopride. J Neurol Sci 132:156–161PubMedCrossRef

12.

Narang N, Wamsley JK (1995) Time dependent changes in DA uptake sites, D₁ and D₂ receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 9:41–53PubMedCrossRef

13.

Nikolaus S, Larisch R, Beu M, Vosberg H, Muller-Gartner HW (2001) Imaging of striatal dopamine D₂ receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: A validation study with ¹⁸F-(N-Methyl)Benperidol. J Nucl Med 42:1691–1696PubMed

14.

Doudet DJ, Jivan S, Ruth TJ, Holden JE (2002) Density and affinity of the dopamine D₂ receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [¹¹C]raclopride. Synapse 44:198–202PubMedCrossRef

15.

Wilson JM, Nobrega JN, Carroll ME, et al. (1994) Heterogeneous subregional binding patterns of ³H-WIN 35,428 and ³H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966–2979PubMed

16.

Kilbourn MR, Sherman PS, Pisani T (1992) Repeated reserpine administration reduces in vivo [¹⁸F]GBR 13119 binding to the dopamine uptake site. Eur J Pharmacol 216:109–112PubMedCrossRef

17.

Doudet DJ (2001) PET studies in the MPTP model of Parkinson's disease. Adv Neurol 86:187–195PubMed

18.

Lee CS, Samii A, Sossi V, et al. (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 47:493–503PubMedCrossRef

19.

Wilson JM, Kish SJ (1996) The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16:3507–3510PubMed

20.

Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K (1995) The vesicular monoamine transporter is not regulated by dopaminergic treatments. Eur J Pharmacol 294:577–583CrossRef

21.

Frey KA, Wieland DM, Kilbourn MR (1998) Imaging of monoaminergic and cholinergic vesicular transporters in the brain. Adv Pharmacol 42:269–272PubMedCrossRef

22.

Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. San Diego: Academic Press

23.

Schallert T, Woodlee MT (2005) Orienting and Placing. In: Whishaw IQ, Kolb B (eds) The Behavior of the Laboratory Rat: A Handbook with Tests. New York: Oxford University Press, pp 129–140

24.

Zhao CS, Puurunen K, Schallert T, Sivenius J, Jolkkonen J (2005) Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 158:211–220PubMedCrossRef

25.

Feeney DM, Gonzalez A, Law WA (1982) Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217:855–857PubMedCrossRef

26.

Walsh SL, Wagner GC (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 263:617–626PubMed

27.

Bowenkamp KE, Ujhelyi L, Cline EJ, Bickford PC (2000) Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats. Neurobiol Aging 21:117–124PubMedCrossRef

28.

Zar JH (1999) Biostatistical Analysis. Upper Saddle River: Prentice-Hall

29.

Rubins DJ, Meadors AK, Yee S, Melega WP, Cherry SR (2001) Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies. J Neurosci Methods 107:63–70PubMedCrossRef

30.

Jewett DM, Kilbourn MR, Lee LC (1997) A simple synthesis of [¹¹C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 24:197–199PubMedCrossRef

31.

Alexoff D, Vaska P, Marsteller D, et al. (2003) Reproducibility of 11C-raclopride binding in the rat brain measured with microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med 44:815–822PubMed

32.

Strome EM, Jivan S, Doudet DJ (2005) Quantitative in vitro phosphor imaging using [³H] and [¹⁸F] radioligands: The effects of chronic desipramine treatment on serotonin 5-HT₂ receptors. J Neurosci Methods 141:143–154PubMedCrossRef

33.

Darchen F, Masuo Y, Vial M, Rostene W, Scherman D (1989) Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [³H]dihydrotetrabenazine and 7-amino-8-[¹²⁵I]iodoketanserin. Neuroscience 33:341–349PubMedCrossRef

34.

Masuo Y, Pelaprat D, Scherman D, Rostene W (1990) [³H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Neurosci Lett 114:45–50PubMedCrossRef

35.

Nikolaus S, Larisch R, Beu M, et al. (2003) In vivo measurement of D₂ receptor density and affinity for ¹⁸F-(3-N-methyl) benperidol in the rat striatum with a PET system for small laboratory animals. J Nucl Med 44:618–624PubMed

36.

Matsumura A, Mizokawa S, Tanaka M, et al. (2003) Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: Comparison between quantitative data obtained with microPET and ex vivo autoradiography. Neuroimage 20:2040–2050PubMedCrossRef

37.

Moore AH, Osteen CL, Chatziioannou A, Hovda DA, Cherry SR (2000) Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET. J Cereb Blood Flow Metab 20:1492–1501PubMedCrossRef

38.

Momosaki S, Hatano K, Kawasumi Y, et al. (2004) Rat-PET study without anesthesia: Anesthetics modify the dopamine D₁ receptor binding in rat brain. Synapse 54:207–213PubMedCrossRef

39.

Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000) Effects of (S)-ketamine on striatal dopamine: A [¹¹C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34:35–43PubMedCrossRef

40.

Kobayashi K, Inoue O, Watanabe Y, Onoe H, Langstrom B (1995) Difference in response of D₂ receptor binding between ¹¹C-N-methylspiperone and ¹¹C-raclopride against anesthetics in rhesus monkey brain. J Neural Transm Gen Sect 100:147–151PubMedCrossRef

41.

Mazziotta JC, Phelps ME, Plummer D, Kuhl DE (1981) Quantitation in positron emission computed tomography: 5. Physical–anatomical effects. J Comput Assist Tomogr 5:734–743PubMedCrossRef

42.

Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777–787PubMedCrossRef

Title: Evaluation of the Integrity of the Dopamine System in a Rodent Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Compared to Behavioral Assessment and Autoradiography
Authors: Elissa M. Strome
Ivan L. Cepeda
Vesna Sossi
Doris J. Doudet
Publication date: 01-09-2006
Publisher: Springer-Verlag
Published in: Molecular Imaging and Biology / Issue 5/2006
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-006-0051-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of the Integrity of the Dopamine System in a Rodent Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Compared to Behavioral Assessment and Autoradiography

Abstract

Purpose

Procedures

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Procedures

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2006

Improved Delivery in Cell Culture of Radiolabeled Antisense DNAs by Duplex Formation

Commentary

2-Deoxy-2-[18F]fluoro-d-glucose-Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Diagnosis of Patients with Recurrent Papillary Thyroid Cancer

Deficit Reduction Act of 2005 and its Adverse Impact on Medicare Beneficiary Access to Positron Emission Tomography

Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography

Preclinical Acute Toxicity Studies and Dosimetry Estimates of the Novel Sigma-1 Receptor Radiotracer, [18F]SFE